Genetics of t(11;14)(q13;q32)-negative MCL

被引：0
作者：
Wlodarska, I.
Vanhentenrijk, V.
Pospisilova, H.
Van Roosbroeck, K.
Stul, M.
Francesca, M.
Dierickx, D.
Verhoef, G.
Vandenberghe, P.
Dewolf-Peeters, C.
机构：
[1] Univ Leuven, Dept Pathol, Louvain, Belgium
[2] Univ Leuven, Dept Hematol, Louvain, Belgium
来源：
ACTA CLINICA BELGICA | 2007年 / 62卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
[21]   13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): A cytogenetic and interphase cytogenetic study [J].
Bigoni, R ;
Cuneo, A ;
Roberti, MG ;
Bardi, A ;
Rigolin, GM ;
Campioni, D ;
Pedriali, L ;
Piva, N ;
Bullrich, F ;
Croce, C ;
Castoldi, GL .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) :144-144
[22]   High incidence of translocations t(11;14) (q13;q32) and t(4;14) (p16;q32) in patients with plasma cell malignancies. [J].
Avet-Loiseau, H ;
Li, JY ;
Facon, T ;
Brigaudeau, C ;
Morineau, N ;
Maloisel, F ;
Rapp, MJ ;
Talmant, P ;
Trimoreau, F ;
Jaccard, A ;
Harousseau, JL ;
Bataille, R .
BLOOD, 1998, 92 (10) :716A-717A
[23]   The (11;14)(q13;q32) translocation in multiple myeloma - A morphologic and immunohistochemical study [J].
Hoyer, JD ;
Hanson, CA ;
Fonseca, R ;
Greipp, PR ;
Dewald, GW ;
Kurtin, PJ .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (06) :831-837
[24]   Large variation in t(11;14)(q13;q32) and t(14;18)(q32;q21) translocation product size is confirmed by sequence analysis of PCR products [J].
Wickham, C. L. ;
Harries, L. W. ;
Sarsfield, P. ;
Joyner, M. V. ;
Ellard, S. .
CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (04) :248-253
[25]   TRANSLOCATION (12 14)(Q13 Q32) IN MYELODYSPLASTIC SYNDROME [J].
BADIA, L ;
ALVAREZ, MA ;
PALAU, F ;
PRIETO, F .
CANCER GENETICS AND CYTOGENETICS, 1993, 65 (01) :76-78
[26]   Acquisition of a t(11;14)(q13;q32) in clonal evolution in a follicular lymphoma with a t(14;18)(q32;q21) and t(3;22)(q27;q11.2) [J].
Koduru, Prasad R. ;
Chen, Weina ;
Garcia, Rolando ;
Fuda, Franklin .
CANCER GENETICS, 2015, 208 (06) :303-309
[27]   Favorable survival of multiple myeloma patients with t(11;14)(q13;q32) plus normal chromosome 13q. [J].
Kaufmann, H ;
Baldia, C ;
Ackermann, J ;
Noesslinger, T ;
Gisslinger, H ;
Jaeger, U ;
Sagaster, V ;
Seidl, S ;
Keck, A ;
Ludwig, H ;
Simonitsch-Klupp, I ;
Zielinski, C ;
Drach, J .
BLOOD, 2004, 104 (11) :942A-942A
[28]   Correlation Between Losses of IGH or Its Segments and Deletions of 13q14 in t(11;14)(q13;q32) Multiple Myeloma [J].
Trakhtenbrot, Luba ;
Hardan, Izhar ;
Koren-Michowitz, Maya ;
Oren, Shirley ;
Yshoev, Galina ;
Rechavi, Gideon ;
Nagler, Arnon ;
Amariglio, Ninette .
GENES CHROMOSOMES & CANCER, 2010, 49 (01) :17-27
[29]   Overexpression of the PRAD1 oncogene in a patient with prolymphocytic leukemia with t(11;14)(q13;q32) [J].
Kobayashi, H ;
Kitano, K ;
Saito, H ;
Aoki, K ;
Narita, A ;
Terada, N ;
Sonoyama, M ;
Uchimaru, K ;
Machii, T ;
Motokura, T .
CANCER GENETICS AND CYTOGENETICS, 1995, 84 (01) :69-72
[30]   Frequent allelic loss of the BCL10 gene in lymphomas with the t(11;14)(q13;q32) [J].
D Steinemann ;
R Siebert ;
S Harder ;
I Martin-Subero ;
G Kettwig ;
B Hinzmann ;
S Gesk ;
M Tiemann ;
H Merz ;
A Rosenthal ;
W Grote ;
SW Morris ;
B Schlegelberger .
Leukemia, 2001, 15 :474-475
12345